Lineage Cell Therapeutics, Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Anna Paulina LunaHouse · R · FL |
LCTXLineage Cell Therapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jan 29, 2024 | Jan 4, 2024 | Filing ↗ |
Whale Activity
- Increased41
- New27
- Held42
- Decreased28
- Closed16
- No prior filing5
| Filer | Shares | Value | Change |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 49.6M | $47.4M | held |
| BlackRock, Inc. | 13.9M | $13.3M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.8M | $8.4M | decreased |
| Defender Capital, LLC. | 6.6M | $6.4M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 5.3M | $5.1M | increased |
| RAFFLES ASSOCIATES LP | 5.2M | $5.0M | held |
| FIFTH THIRD BANCORP | 4.9M | $4.7M | increased |
| STATE STREET CORP | 2.9M | $2.8M | increased |
| MILLENNIUM MANAGEMENT LLC | 2.6M | $2.5M | decreased |
| VANGUARD FIDUCIARY TRUST CO | 1.7M | $1.6M | increased |
| NORTHERN TRUST CORP | 1.7M | $1.6M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $1.2M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Mulroy Michael H.Director · Director | Purchase | +30.0K | $0.87 | $26K | Nov 17, 2026 | Form 4 ↗ |
| BROADWOOD PARTNERS, L.P. / BROADWOOD CAPITAL INC / Bradsher Neal CDirector · Director | Purchase | +1.0M | $0.77 | $771K | Nov 17, 2026 | Form 4 ↗ |
| BROADWOOD PARTNERS, L.P. / BROADWOOD CAPITAL INC / Bradsher Neal CDirector · Director | Purchase | +0 | $0.00 | $0 | Nov 17, 2026 | Form 4 ↗ |
| ANDREWS DEBORAH JDirector · Director | Purchase | +25.0K | $0.80 | $20K | Nov 16, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Purchase | +40.5K | $0.92 | $37K | Nov 16, 2026 | Form 4 ↗ |
| Howe Jill AnnChief Financial Officer | Purchase | +20.0K | $0.85 | $17K | Nov 16, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Purchase | +15.0K | $1.63 | $24K | Mar 12, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −12.9K | $1.80 | $23K | Feb 11, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Option exercise | +31.3K | — | — | Feb 11, 2026 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Tax withholding | −2,502 | $1.80 | $5K | Feb 11, 2026 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Option exercise | +6,075 | — | — | Feb 11, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −334 | $1.68 | $561 | Dec 19, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Grant / award | +8,925 | — | — | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Tax withholding | −65 | $1.68 | $109 | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Grant / award | +1,735 | — | — | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel | Tax withholding | −2,440 | $0.65 | $2K | Feb 11, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel | Option exercise | +6,076 | — | — | Feb 11, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −12.5K | $0.65 | $8K | Feb 11, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Option exercise | +31.2K | — | — | Feb 11, 2025 | Form 4 ↗ |
| BROADWOOD CAPITAL INC10% owner | Purchase | +0 | $0.00 | $0 | Jan 27, 2025 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.9M | $7.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 4.2M | $5.4M | 0.01% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.0M | $3.9M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 1.7M | $2.3M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 2.0M | $2.2M | 0.01% | Jul 31, 2026 |
| iShares Biotechnology ETF iShares Trust | 1.3M | $1.7M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1.3M | $1.4M | 0.00% | Aug 31, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 1.1M | $1.2M | 0.01% | Aug 31, 2026 |
| iShares Micro-Cap ETF iShares Trust | 617.2K | $808K | 0.05% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 447.5K | $483K | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list LCTX's shares (CUSIP 53566P109), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- BlackRock, Inc.SCHEDULE 13G · passive (13G) · 13.2M shares5.3%
Jul 29, 2026 · ↗
Corporate Lobbying
No lobbying filings found naming Lineage Cell Therapeutics, Inc. as the client.
Government Contracts
No federal contract awards found for Lineage Cell Therapeutics, Inc..
U.S. Patents
No USPTO patent applications found for Lineage Cell Therapeutics, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $14.6M | $9.5M | $8.9M | $14.7M | $4.3M |
| Operating income | -$36.6M | -$21.5M | -$24.7M | -$22.5M | -$49.2M |
| Net income | -$63.5M | -$18.6M | -$21.5M | -$26.3M | -$43.0M |
| Diluted EPS | -$0.28 | -$0.09 | -$0.12 | -$0.15 | n/a |
| Operating cash flow | -$18.9M | -$23.1M | -$28.6M | $1.1M | -$23.6M |
| Cash and equivalents | $40.8M | $45.8M | $35.4M | $11.4M | $55.7M |
| Total assets | $112.6M | $113.2M | $101.0M | $123.7M | $174.5M |
| Total liabilities | $69.2M | $36.2M | $39.0M | $51.7M | $83.6M |
| Shareholders' equity | $44.5M | $78.4M | $63.4M | $73.3M | $92.2M |
As Lineage Cell Therapeutics, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 5, 2026 ↗
Stock Splits
- 8-for-7Stock splitNov 29, 2018
- 13-for-12Stock splitJan 4, 2016
- 3-for-1Stock splitOct 31, 1997
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 1.01, 2.01, 2.02, 3.02, 7.01, 9.01Material agreement · Acquisition or disposition · Results of operationsNov 12, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.07, 8.01Shareholder vote · Other eventsJun 12, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 12, 2026
EDGAR ↗

